The use of dexmedetomidine in intensive care sedation

Massimo Antonelli(Università Cattolica del Sacro Cuore), Marco Ranieri(Commissariat à l'Énergie Atomique et aux Énergies Alternatives), Patrizio Piacentini(Ospedale San Carlo), Lucia Sara D’Angiolella, Andrea Belisari(Fondazione Progetto Ematologia), Giorgio Conti(Università Cattolica del Sacro Cuore), LG Mantovani(IRCCS Istituto Auxologico Italiano), Sabato Montella(Parthenope University of Naples)
Farmeconomia Health economics and therapeutic pathways
May 28, 2013
10.7175/fe.v14i1s.674
Cited by 0

Related Papers

Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016
|Intensive Care Medicine|2017|6.8k
Epidemiology, Patterns of Care, and Mortality for Patients With Acute Respiratory Distress Syndrome in Intensive Care Units in 50 Countries
|JAMA|2016|5.9k
Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021
|Intensive Care Medicine|2021|5.1k
Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016
|Critical Care Medicine|2017|3.8k
Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock 2021
|Critical Care Medicine|2021|2.8k